Canada set the amount for this week to receive 2M Pfizer, as the company ramped up delivery


Canada is set to receive more than two million doses of the Pfizer-BioNtech vaccine each week as the two pharmaceutical companies complete their deliveries and begin shipping shots from the United States.

Pfizer and BioNTech have been consistently offering around a million doses from Brussels each week since mid-March, but this number will double from next month before increasing further in June.

This week’s dose also includes Kalamazoo, Mich. Will be the first to arrive from Pfizer’s plant in the US, after the US government has already banned vaccine exports to vaccinate its own citizens.

Read more:

Canada is holding back its 1-shot J & J COVID-19 vaccine. Here you need to know

However, there was no immediate word on progress in negotiations with the US over the provision of an overdose of the Oxford-AstraZeneca vaccine, which is in high demand across the country.

Story continues under advertisement

Federal Public Service and Procurement Minister Anita Anand said on Friday that Ottawa was “very aggressive, especially with the supplier.”

US President Joe Biden suggested last month that the US could share tens of tens of its AstraZeneca shots, which health officials there have not approved for use.

Many provinces have skyrocketed demand for the shot even after the eligible age for the vaccine is over 40, and Anand has said that Canada will receive a total of 4 million doses by the end of June, but the government does not have a detailed schedule That when will they actually arrive.

Pfizer-BioNTech doses are the only shots scheduled to arrive in Canada in the next seven days, with Modern expected to deliver the next batch of more than 1 million doses next week.

The Feds have also not said when they will release a single-shot vaccine dose from Johnson & Johnson after the first 300,000 jobs in Canada last week.


Click to play video: 'Former FDA Commissioner' Pfizer COVID-19 Vaccine Approval for Children 'Hopeful'



Former FDA Commissioner ‘Hopeful’ for Pfizer COVID-19 Vaccine Approval for Children


Former FDA Commissioner ‘Hopeful’ for Pfizer COVID-19 Vaccine Approval for Children

Some of the items learned by Health Canada are now planned to be delivered in Maryland after being manufactured in Maryland, which remains part of the production process for 15 million doses for the US.

Story continues under advertisement

The country’s Food and Drug Administration recently cited the facility for violations, including cleaning and sterilization failures, the ability to cross-contamination, and failure to follow the required protocols.

Health Canada had already cleared 1.5 million doses of the AstraZeneca vaccine made at the facility, but did not consider that Canadian J&J supplements had any connection to that plant.

Now Health Canada says that the intoxicant that was part of the J&J vaccine was actually produced there and then sent elsewhere for the vaccine to end.

The push for more shots comes as lockdowns continue in many parts of the country, while a third wave of COVID-19 infections, exacerbated by multiple variants of the novel coronovirus, rages across Canada.

READ MORE: Experts say it is easier for Canadians to get vaccinated in the US

However, against that backdrop, some long-standing virus hot spots set out to intensify their vaccination efforts.

Both Quebec and Ontario are set to lower the eligibility age for vaccination, with the latter province also planning to redirect its supplies to designated neighborhoods with higher infection rates over the next two weeks.

More than 173,000 new vaccinations were reported across the country on Saturday, bringing the total dose to 13,825,476.

Story continues under advertisement

Nationwide, 1,128,778 people, or 3 percent, have been fully vaccinated.

View link »


© 2021 Canadian Press

.

Latest articles

Related articles